Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Tumori|May 23, 2020
Finalization of autologous stem cell transplant in complex and multirelapsed follicular lymphomaMatteo Carella, Vittorio Stefoni, Cinzia Pellegrini, et al.
Clinical Case Reports|June 25, 2020
Management of central nervous system relapse in a young patient affected by primary mediastinal large B-cell lymphoma: A case reportMiriam Marangon, Beatrice Casadei, Alessandro Broccoli, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 19, 2012
Non-hodgkin lymphomas presenting as soft tissue masses: a single center experience and meta-analysis of the published seriesEnrico Derenzini, Beatrice Casadei, Cinzia Pellegrini, et al.
Tumori|June 25, 2021
Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case reportGinevra Lolli, Beatrice Casadei, Cinzia Pellegrini, et al.
Tumori|March 13, 2020
Chronic lymphocytic leukemia focus in the context of a cardiac mass in a pretreated patient: an exceptional incidental findingGinevra Lolli, Alessandro Broccoli, Vittorio Stefoni, et al.
Hematological Oncology|August 4, 2018
Siltuximab in relapsed/refractory multicentric Castleman disease: Experience of the Italian NPP programLorenzo Tonialini, Maurizio Bonfichi, Simone Ferrero, et al.
BMC Cancer|June 9, 2018
A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case reportAlessandro Broccoli, Laura Nanni, Vittorio Stefoni, et al.
Frontiers in Medicine|October 22, 2021
Rheumatoid Arthritis and Cardiovascular Risk: Retrospective Matched-Cohort Analysis Based on the RECORD Study of the Italian Society for RheumatologyLisa Argnani, Anna Zanetti, Greta Carrara, et al.
Scientific Reports|February 3, 2022
Immune-related adverse events in the treatment of non-Hodgkin lymphoma with immune checkpoint inhibitorsLisa Argnani, Beatrice Casadei, Carla Pelusi, et al.
Hematological Oncology|January 15, 2019
A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapiesLaura Nanni, Alice Morigi, Beatrice Casadei, et al.
Pageof 10